
JBIO Market Capitalization Overview
Market Cap: $609.56M as of Jan 8, 2026
$609.56M
$11.51M (1.85%)past month
As of Jan 8, 2026, JBIO has a market capitalization of $609.56M. Over the past 30 days, its market cap has increased by 17.02%, while in the last 12 months, it has decreased by -14.13%.
Market capitalization represents the total value of Aerovate Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
JBIO Market Cap Formula = Stock Price * Shares Outstanding
The market cap of JBIO helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Aerovate Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
JBIO Market Cap Formula = Stock Price * Shares Outstanding
The market cap of JBIO helps investors assess the company's size and compare it with competitors for better investment decisions.
JBIO Market Cap & Key Trends
See Aerovate Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in JBIO
Order type
Buy in
Order amount
Est. shares
0 shares
JBIO Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $556.66M | +80.16% |
| Nov 3, 2025 | $308.98M | +3.95% |
| Oct 1, 2025 | $297.23M | +19.55% |
| Sep 2, 2025 | $248.62M | +11.94% |
| Aug 1, 2025 | $222.11M | -36.47% |
| Jul 1, 2025 | $349.60M | +5,171.86% |
| Jun 2, 2025 | $6.64M | -19.92% |
| May 1, 2025 | $8.29M | -88.62% |
| Apr 1, 2025 | $72.76M | +4.58% |
| Mar 3, 2025 | $69.57M | -7.34% |
| Feb 3, 2025 | $75.08M | -3.54% |
| Jan 2, 2025 | $77.83M | +1.35% |
JBIO End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $609.56M | -14.13% |
| 2025 | $709.85M | +824.15% |
| 2024 | $76.82M | -87.73% |
| 2023 | $625.80M | -12.85% |
| 2022 | $718.04M | +149.49% |
| 2021 | $287.80M | — |
FAQs About Aerovate Therapeutics Inc (JBIO) Market Cap
As of Jan 8, 2026, the market capitalization of JBIO is $609.56M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Aerovate Therapeutics Inc’s market capitalization has decreased by -1.85%, changing from $621.06M to $609.56M as of Jan 8, 2026.
In the last 3 months, Aerovate Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Aerovate Therapeutics Inc’s market capitalization increased from $76.82M in January to $709.85M in December, reflecting a 824.15% change.
In the past five years, JBIO has had a compound annual growth rate (CAGR) of 19.79% in market capitalization. This means its market cap has grown at an average rate of 19.79% per year.